{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:44:06Z","timestamp":1791330246010,"version":"4.3.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-086037"],"award-info":[{"award-number":["AI-086037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-48693"],"award-info":[{"award-number":["AI-48693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 101093"],"award-info":[{"award-number":["AI 101093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.clim.2020.108362","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:38:43Z","timestamp":1581439123000},"page":"108362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series"],"prefix":"10.1016","volume":"212","author":[{"given":"Travis","family":"Sifers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hirten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mehandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin Mabel","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108362_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2020.108362_bb0010","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108362_bb0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"Collaborators, the European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2020.108362_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2020.108362_bb0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2020.108362_bb0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/ajg.2016.329","article-title":"A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency","volume":"111","author":"Jorgensen","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2020.108362_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11894-016-0491-3","article-title":"Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD)","volume":"18","author":"Uzzan","year":"2016","journal-title":"Current Gastroenterology Reports"},{"key":"10.1016\/j.clim.2020.108362_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clim.2020.108362_bb0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.14309\/ajg.0000000000000140","article-title":"A high prevalence of gastrointestinal manifestations in common variable immunodeficiency","volume":"114","author":"Pikkarainen","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2020.108362_bb0050","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2020.108362_bb0055","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ajg.2017.246","article-title":"Vedolizumab in patients with common variable immune deficiency and gut inflammation","volume":"112","author":"Boland","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2020.108362_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izaa012","article-title":"Vedolizumab induced clinical, endoscopic, and histological improvement in common variable immunodeficiency disease-associated intestinal enteropathy","author":"Akhtar","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.clim.2020.108362_bb0065","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.clim.2020.108362_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0032-1326078","article-title":"Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia","volume":"45","author":"Maarschalk-Ellerbroek","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.clim.2020.108362_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/00365521.2019.1568543","article-title":"The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy","volume":"54","author":"Pensieri","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.clim.2020.108362_bb0080","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2020.108362_bb0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2006.06.022","article-title":"Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency","volume":"131","author":"Mannon","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2020.108362_bb0090","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.clim.2020.108362_bb0095","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108362_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2020.108362_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clim.2017.03.006","article-title":"Increase of circulating alpha4beta7(+) conventional memory CD4 and regulatory T cells in patients with common variable immunodeficiency (CVID)","volume":"180","author":"de Melo","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108362_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2016.08.042","article-title":"Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis","volume":"139","author":"Navarini","year":"2017","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:59:19Z","timestamp":1761494359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620300838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"alternative-id":["S1521661620300838"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108362","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108362"}}